Directory
>
Mark Gergen
Mark Gergen
Executive Chairman | Poseida Therapeutics, Inc.
San Diego, California, United States
Mark Gergen
Summary
Mark Gergen is an accomplished executive in the biopharmaceutical and medical device sectors, currently serving as the Executive Chairman of Poseida Therapeutics. With a robust track record that includes leadership roles such as Chairman and CEO, he has consistently driven growth and innovation in the companies he has led. Mark's expertise spans a wide array of areas including business development, corporate governance, and strategic partnerships, making him a key figure in the biotechnology landscape. He has held pivotal positions in various organizations, contributing to significant advancements in drug development and commercialization. Mark holds a JD from the University of Minnesota Law School and a BA in Business Administration from Minot State University, reflecting a strong foundation in both law and business. His leadership style emphasizes strategic foresight and cross-functional team collaboration, which has been instrumental in navigating complex industry challenges. Mark's contributions extend beyond executive roles, as he actively participates on boards, providing guidance and insight to emerging companies. His passion for advancing healthcare solutions is evident in his commitment to fostering innovation and collaboration in the life sciences field.
Mark Gergen
Work Experience
Executive Chairman at
Poseida Therapeutics, Inc.
January 2024 - Present
Chairman and Chief Executive Officer at
Poseida Therapeutics, Inc.
February 2022 - December 2023
Independent Board Member at
Aristea Therapeutics
January 2022 - January 2023
President, Chief Business Officer and Director at
Poseida Therapeutics, Inc.
July 2020 - January 2022
Chief Business Officer, Chief Financial Officer and Director at
Poseida Therapeutics, Inc.
February 2018 - June 2020
Chief Operating Officer / Consultant at
Halozyme, Inc.
January 2016 - January 2018
Executive Vice President at
Bristol Myers Squibb
January 2013 - January 2016
Senior Vice President, Corporate Development at
Amylin Pharmaceuticals
January 2005 - January 2012
Director at
APERIO TECHNOLOGIES PRIVATE LIMITED
January 2003 - January 2012
Executive Vice President at
Biotelemetry Healthcare Formerly Cardionet
January 2003 - January 2005
Chief Restructuring Officer, Senior Vice President at
Advanced Tissue Sciences
January 2000 - January 2003
Assistant General Counsel at
Premeir Inc
January 1999 - January 2000
Various at
MEDTRONIC LIMITED
January 1994 - January 1999
Mark Gergen
Education
Frequently Asked Questions about Mark Gergen
What is Mark Gergen email address?
Mark Gergen's primary email address is *******@aristeatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mark Gergen work for?
Mark Gergen is a Executive Chairman at Poseida Therapeutics, Inc., a company specializing in Commercial physical research.
Where Mark Gergen graduated from?
Mark Gergen holds a degree in Law from University of Minnesota Law School.
How can I directly contact Mark Gergen?
To contact Mark Gergen directly, you can use the email address *******@aristeatx.com. Complete contact information is available upon registration with Muraena.
Who is Mark Gergen?
Mark Gergen is an accomplished executive in the biopharmaceutical and medical device sectors, currently serving as the Executive Chairman of Poseida Therapeutics. With a robust track record that includes leadership roles such as Chairman and CEO, he has consistently driven growth and innovation in the companies he has led. Mark's expertise spans a wide array of areas including business development, corporate governance, and strategic partnerships, making him a key figure in the biotechnology landscape. He has held pivotal positions in various organizations, contributing to significant advancements in drug development and commercialization. Mark holds a JD from the University of Minnesota Law School and a BA in Business Administration from Minot State University, reflecting a strong foundation in both law and business. His leadership style emphasizes strategic foresight and cross-functional team collaboration, which has been instrumental in navigating complex industry challenges. Mark's contributions extend beyond executive roles, as he actively participates on boards, providing guidance and insight to emerging companies. His passion for advancing healthcare solutions is evident in his commitment to fostering innovation and collaboration in the life sciences field.
Mark`s contact details
*******@aristeatx.com
*******@poseida.com
*******@novatelwireless.com
*******@mirati.com
***********@premierinc.com
Colleagues
Chief Scientific Officer, Gene Therapy
Vice President, Head of Statistical and Data Sciences
General Counsel, Chief Compliance Officer & Corporate Secretary
Vice President, Information Technology
Chief People & Administration Officer
Senior Vice President Regulatory Affairs
Vice President, Cinical Development
Vice President R&D, Gene Therapy
Vice President of Immuno-Oncology
VP, Intellectual Property